Pune, India, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The Europe facial injectable market size was USD 1.98 billion in 2022, and it is projected to grow from USD 2.08 billion in 2023 to USD 3.14 billion by 2030, exhibiting a CAGR of 6.0% during the forecast period. Facial injectables are substances injected under the skin to enhance the skin by minimizing the wrinkles on the skin. The increasing demand for the product is attracting prominent players to invest in R&D activities to augment market growth and the development of novel products.
This information is provided by Fortune Business Insights in its report titled, “Europe Facial Injectable Market, 2023-2030.”
Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/europe-facial-injectable-market-106778
Key Industry Development:
March 2023 - Galderma announced the launch of FACE by Galderma, an innovative aesthetic visualization tool powered by Augmented Reality (AR) that simulates injectable treatment results in real time.
Key Takeaways
- The growth of the facial injectable market is being driven by the rising demand for non-invasive cosmetic procedures, the increasing awareness about facial injectable procedures, and the growing disposable income of people in Europe.
- The Europe facial injectable market is segmented by product type, application, and end-user.
- The key players in the facial injectable market are Allergan, Galderma, Merz Aesthetics, Medtronic, and Johnson & Johnson.
- These companies are investing in research and development, new product development, and marketing to maintain their competitive edge in the market.
- The Europe facial injectable market is facing some challenges, such as the increasing competition from other non-invasive cosmetic procedures, the stringent regulatory environment, and the potential side effects of facial injectable procedures.
Discover the Leading Players Featured in the Report:
Companies leading the Europe facial injectable market are Allergan Aesthetics (AbbVie Inc.) (U.S.), Ipsen Pharma (France), Merz Pharma (Germany), Galderma (Switzerland), Revance Therapeutics, Inc. (U.S.), Sinclair Pharma (U.K.), BIOPLUS CO., LTD. (South Korea), Bioxis pharmaceuticals (France), Prollenium Medical Technologies (Canada).
Report Scope
| Report Coverage | Details |
| Forecast Period | 2023 to 2030 |
| Forecast Period 2023 to 2030 CAGR | 6.0% |
| 2030 Value Projection | USD 3.14 Billion |
| Base Year | 2022 |
| Market Size in 2023 | USD 2.08 Billion |
| Historical Data | 2019-2021 |
| No. of Pages | 110 |
| Segments Covered | By Type, Application, End-user & Region |
Browse Complete Report Details: https://www.fortunebusinessinsights.com/europe-facial-injectable-market-106778
Drivers and Restraints:
Rise in Demand for Aesthetic Cosmetic Procedures to Fuel the Europe Facial Injectable Market Growth
In Europe, the demand for cosmetic surgical procedures and negligibly invasive or non-invasive cosmetic processes, such as botulinum toxin and dermal filler injections, has augmented enormously over the last decade. Cosmetic techniques that are invasive often necessitate patients to take definite additional days for recuperation from surgical procedures. Hence, many people are rooting for minimally invasive facial injectable processes that are pain-free and effortless.
Comparative side effects and the high cost of such procedures are expected to hinder the market growth during the projected period.
Segmentation
By Type
- Botulinum Toxin
- Collagen
- Hyaluronic Acid
- Calcium Hydroxylapatite
- Polylactic Acid
- PMMA
- Fat Injection
- Others
By Application
- Wrinkle Reduction
- Facelift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Lip Enhancement
- Others
By End-user
- Hospitals & Ambulatory Surgery Centers
- Dermatology and Cosmetic Clinics
- Others
By Country/Sub-region
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Netherlands
- Greece
- Belgium
- Rest of Europe
Quick Buy - Europe Facial Injectable Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/106778
Country Insights:
Germany Leads the Market due to Increased Adoption of Cosmetic Procedures
The German market size stood at USD 0.48 billion in 2022 and is anticipated to observe sturdy growth trends during the forecast period. The robust volume of cosmetic processes, such as botulinum toxin and several dermal fillers, across Germany is projected to boost the market. Further, huge spending on research & development actions by prime companies in Germany is anticipated to fuel the growth of the market over the forecast period.
France is anticipated to account for the second-highest Europe facial injectable market share in Europe during the forecast period of 2023-2030 due to a rise in the number of fresh product launches and injectable facial procedures.
Ask For Customization: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/europe-facial-injectable-market-106778
Competitive Landscape:
Innovative Product Launches by Crucial Players to Boost Market Growth
The fundamental players adopt numerous tactics to bolster their position as dominating companies in the market. One such effective strategy is periodically launching radical products with a systematic review of the market and its target audience.
FAQs
How big is the Europe Facial Injectable Market?
The global market size is USD 2.08 billion in 2023. It is expected to reach USD 3.14 billion by 2030.
How fast is the Europe Facial Injectable Market growing?
The global market will exhibit a CAGR of 6.0% during the forecast period 2023-2030.
Related Reports:
Facial Injectables Market Size, Share, Revenue Forecast and Opportunities
Dermal Fillers Market Overview, Industry Share and Forecast
Cosmetic Surgery Market Size, Share, Opportunities & Analysis
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Attachment
